Lawrence is the President of SiO2 Materials Science, a company focused on three core segments: Pharmaceuticals, Molecular Diagnostics, and Consumer Healthcare. Given a $143 million investment grant from the U.S. government, SiO2 is on a mission to tackle the vaccine vial shortage. They hold over 300 patents and are known for their unique glass like barrier for application onto any plastic surface so as to increase its durability. Throughout the Covid Crisis, demand for this material has surged, presenting a novel opportunity for SiO2. To date, they have supplied vials for over 100 million Covid vaccine doses. Lawrence holds a Bachelors of Science in Entrepreneurship from Babson College and was previously the CEO of Innoplexus.

Lawrence joins us to discuss the products that SiO2 offer, how SiO2 scaled during Covid, and trends in the Materials Science space.

https://www.sio2ms.com/